Obesity and polycystic ovary syndrome

被引:348
|
作者
Barber, T. M.
McCarthy, M. I.
Wass, J. A. H.
Franks, S.
机构
[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford, England
[2] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Dept Endocrinol, Oxford, England
[3] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England
关键词
D O I
10.1111/j.1365-2265.2006.02587.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aetiology of Polycystic Ovary Syndrome (PCOS) is complex and multifactorial. There is much evidence, however, to suggest that adipose tissue plays an important role in the development and maintenance of PCOS pathology. There is a close correlation between adiposity and symptom severity in women with PCOS, and even modest reductions in weight generally translate into significant improvements in menstrual regularity, fertility and hyperandrogenic features. This review article considers the various mechanisms that might underlie this link between excess adiposity and PCOS - including the effects of differential insulin sensitivity, abnormal steroid hormone metabolism and adipocytokine secretion. Greater attention to the therapeutic options available to reduce the impact of excess adiposity on ovarian and metabolic function is essential to the management of PCOS.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [31] Role of obesity in polycystic ovary syndrome (PCOS)
    Lanzone, A
    Fulghesu, AM
    Guido, M
    Cucinelli, F
    Villa, P
    Ciampelli, M
    Pavone, V
    Murgia, F
    Apa, R
    Cento, R
    Proto, C
    Caruso, A
    Mancuso, S
    OVARY: REGULATION, DYSFUNCTION AND TREATMENT, 1996, 1106 : 229 - 235
  • [32] Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
    Moran, Lisa J.
    Pasquali, Renato
    Teede, Helena J.
    Hoeger, Kathleen M.
    Norman, Robert J.
    FERTILITY AND STERILITY, 2009, 92 (06) : 1966 - 1982
  • [33] Adolescent polycystic ovary syndrome: a postpubertal central obesity syndrome
    de Zegher, Francis
    Ibanez, Lourdes
    FERTILITY AND STERILITY, 2023, 120 (01) : 208 - 208
  • [34] THE SIGNIFICANCE OF OBESITY IN THE POLYCYSTIC-OVARY-SYNDROME (PCO)
    DUNAIF, A
    FLUHR, H
    DOBRJANSKY, A
    CLINICAL RESEARCH, 1986, 34 (03): : A869 - A869
  • [35] Obesity, polycystic ovary syndrome and breastfeeding: an observational study
    Joham, Anju E.
    Nanayakkara, Natalie
    Ranasinha, Sanjeeva
    Zoungas, Sophia
    Boyle, Jacqueline
    Harrison, Cheryce L.
    Forder, Peta
    Loxton, Deborah
    Vanky, Eszter
    Teede, Helena J.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (04) : 458 - 466
  • [36] Obesity contributes to telomere shortening in polycystic ovary syndrome
    Kogure, Gislaine Satyko
    Verruma, Carolina Gennari
    Santana, Barbara A.
    Calado, Rodrigo T.
    Ferriani, Rui Alberto
    Furtado, Cristiana Libardi Miranda
    dos Reis, Rosana Maria
    REPRODUCTIVE SCIENCES, 2024, 31 (06) : 1601 - 1609
  • [37] Obesity and inflammatory biomarkers in women with polycystic ovary syndrome
    Shen, Szu-Hung
    Shen, Szu-Yu
    Liou, Tsan-Hon
    Hsu, Ming-I
    Chang, Yuan-chin Ivan
    Cheng, Chih-Yu
    Hsu, Chun-Sen
    Tzeng, Chii-Ruey
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 192 : 66 - 71
  • [38] Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
    Kahal, Hassan
    Atkin, Stephen L.
    Sathyapalan, Thozhukat
    JOURNAL OF OBESITY, 2011, 2011
  • [39] Obesity, polycystic ovary syndrome and anovulation - how are they interrelated?
    Norman, RJ
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (03) : 323 - 327
  • [40] Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
    Kourtidou, Christodoula
    Tziomalos, Konstantinos
    BIOMEDICINES, 2023, 11 (02)